Pages that link to "Q44695847"

The following pages link to A phase II study of cisplatin and docetaxel administered as three consecutive weekly infusions for advanced non-small-cell lung cancer in elderly patients (Q44695847):

Displaying 17 items.

• Chemotherapy with cisplatin and vinorelbine for elderly patients with locally advanced or metastatic non-small-cell lung cancer (NSCLC) (Q24792196) (← links)
• Phase II trial of weekly docetaxel and gemcitabine as first-line therapy for patients with advanced non-small cell lung cancer (Q33374269) (← links)
• Evaluation of the efficacy and safety of the combination of gemcitabine and nedaplatin for elderly patients with advanced non-small-cell lung cancer (Q33398466) (← links)
• Randomized phase II study comparing weekly docetaxel-cisplatin vs. gemcitabine-cisplatin in elderly or poor performance status patients with advanced non-small cell lung cancer. (Q33440396) (← links)
• Docetaxel versus docetaxel plus cisplatin for non-small-cell lung cancer: a meta-analysis of randomized clinical trials (Q33441413) (← links)
• Review: Treating advanced non-small cell lung cancer in the elderly (Q35076283) (← links)
• Safety profile of platinum-based chemotherapy in the treatment of advanced non-small cell lung cancer in elderly patients (Q36299985) (← links)
• Docetaxel-associated epiphora (Q36484970) (← links)
• A review of the management of elderly patients with non-small-cell lung cancer. (Q38233740) (← links)
• Docetaxel in the treatment of non-small cell lung carcinoma: an update and analysis (Q39139831) (← links)
• Severe hyponatremia caused by nab-paclitaxel-induced syndrome of inappropriate antidiuretic hormone secretion: A case report in a patient with metastatic pancreatic adenocarcinoma (Q42428002) (← links)
• Randomized controlled trial comparing docetaxel-cisplatin combination with weekly docetaxel alone in elderly patients with advanced non-small-cell lung cancer: Japan Clinical Oncology Group (JCOG) 0207†. (Q44685863) (← links)
• Elderly subgroup analysis of a randomized phase III study of docetaxel plus platinum combinations versus vinorelbine plus cisplatin for first-line treatment of advanced nonsmall cell lung carcinoma (TAX 326). (Q46804039) (← links)
• Randomized phase II trial of two different schedules of docetaxel plus cisplatin as first-line therapy in advanced nonsmall cell lung cancer. (Q53578578) (← links)
• [Treatment of non-small cell lung cancer in elderly patients] (Q80467430) (← links)
• Comparison of Carboplatin Plus Pemetrexed Followed by Maintenance Pemetrexed With Docetaxel Monotherapy in Elderly Patients With Advanced Nonsquamous Non-Small Cell Lung Cancer: A Phase 3 Randomized Clinical Trial (Q90259891) (← links)
• Cisplatin-induced renal toxicity in elderly people (Q96135177) (← links)